Genetics at University of Aberdeen is taught at the heart of a very large teaching hospital at Foresterhill. This gives you access to experts within a wide variety of areas including bioinformatics, mendelian genetics, applied statistics and immunogenetics. The MSc degree in Genetics will take you through a wide-ranging curriculum describing some of the latest advances in genetics. You understand how diversity influences clinical outcomes, transplants, infections, autoimmune disease, cancer, immunodeficiency and human reproduction. We have the best support services in the UK to ensure you have guidance from the start.
Graduates from this programme can go on to work in hospital and research laboratories, projects at national and international level to understand health issues, training, scientific publishing, civil service, regulatory areas, government agencies and as consultants to regulators.
Find out more detail by visiting the programme web page
Find out about fees
*Please be advised that some programmes have different tuition fees from those listed above and that some programmes also have additional costs.
View all funding options on our funding database via the programme page
Find out more about:
Find out more about living in Aberdeen and living costs
The language and concepts of infection and immunity, from basic science to translational clinical research, are taught by our world-class investigators. The programme emphasises data interpretation, critical analysis of current literature and culminates in a full-time research project: excellent preparation for a research career.
The programme provides insight into state-of-the-art infection and immunity research, current issues in the biology of infectious agents, the pathogenesis, prevention and control of infectious diseases, and immunity and immune dysfunction.
Students learn from UCL scientists about their research and are trained in the art of research by carrying out a full-time research project in a UCL laboratory.
Students undertake modules to the value of 180 credits.
The programme consists of five core modules (75 credits), three optional modules (45 credits) and a research dissertation (60 credits).
A Postgraduate Diploma comprising four core modules and four optional modules (120 credits, full-time nine months, part-time, flexible study two to five years) is offered.
A Postgraduate Certificate comprising four core modules (60 credits, full-time three months, and flexible study up to two years) is offered.
All MSc students undertake independent research which culminates in a 4,000-word dissertation.
Teaching and learning
The programme is delivered through a combination of lectures, tutorials, paper review sessions, laboratory practicals, an independent research project and self-directed learning. A diverse range of assessment methods is used; coursework may be in the form of presentations, essays, data interpretation exercises, poster preparation, and group working. Many modules also have unseen written examination.
Further information on modules and degree structure is available on the department website: Infection and Immunity MSc
The programme produces graduates who are equipped to embark on research careers. Immersion in the superb research and teaching environment provided by UCL and the Division of Infection & Immunity, gives our graduates a unique understanding of the cutting edge of infection and immunity research and how world-class research is carried out.
Opportunities for networking with UCL senior investigators with international reputations and their worldwide collaborators can provide the inside track for career development. Graduates are well placed to move onto PhD programmes, research positions in diverse biomedical fields, clinical research positions, further training and positions in associated professions.
Recent career destinations for this degree
Graduates are exceptionally well prepared for a career in research. The combination of research-informed teaching and practical research training provides an ideal preparation for a PhD and is equally applicable for clinicians seeking specialist training or wishing to pursue the clinical academic career track.
More broadly, a rigorous grounding in scientific method, critical analysis, data interpretation and independent thinking provides a pallet of marketable and transferable skills applicable to many professional career paths.
Careers data is taken from the ‘Destinations of Leavers from Higher Education’ survey undertaken by HESA looking at the destinations of UK and EU students in the 2013–2015 graduating cohorts six months after graduation.
The UCL Division of Infection & Immunity is a vibrant and world-class research community. Students are embedded in this superb training environment which provides a challenging and stimulating academic experience.
Programme content reflects the research and clinical excellence within the division as well as cross-disciplinary research from all over UCL. First-class teaching and research supervision is provided by UCL academics, many of whom have international reputations.
The Research Excellence Framework, or REF, is the system for assessing the quality of research in UK higher education institutions. The 2014 REF was carried out by the UK's higher education funding bodies, and the results used to allocate research funding from 2015/16.
The following REF score was awarded to the department: Division of Infection & Immunity
80% rated 4* (‘world-leading’) or 3* (‘internationally excellent’)
Learn more about the scope of UCL's research, and browse case studies, on our Research Impact website.
We invite postgraduate research proposals in a number of disease areas that impact significantly on patient care. We focus on exploring the mechanisms of disease, understanding the ways disease impacts patients’ lives, utilising new diagnostic and therapeutic techniques and developing new treatments.
As a student you will be registered with a University research institute, for many this is the Institute for Cellular Medicine (ICM). You will be supported in your studies through a structured programme of supervision and training via our Faculty of Medical Sciences Graduate School.
We undertake the following areas of research and offer MPhil, PhD and MD supervision in:
Newcastle hosts one of the most comprehensive organ transplant programmes in the world. This clinical expertise has developed in parallel with the applied immunobiology and transplantation research group. We are investigating aspects of the immunology of autoimmune diseases and cancer therapy, in addition to transplant rejection. We have themes to understand the interplay of the inflammatory and anti-inflammatory responses by a variety of pathways, and how these can be manipulated for therapeutic purposes. Further research theme focusses on primary immunodeficiency diseases.
There is strong emphasis on the integration of clinical investigation with basic science. Our research include:
We also research the effects of UVR on the skin including mitochondrial DNA damage as a UV biomarker.
This area emphasises on translational research, linking clinical- and laboratory-based science. Key research include:
Focus is on applied research and aims to underpin future clinical applications. Technology-oriented and demand-driven research is conducted which relates directly to health priority areas such as:
This research is sustained through extensive internal and external collaborations with leading UK and European academic and industrial groups, and has the ultimate goal of deploying next-generation diagnostic and therapeutic systems in the hospital and health-care environment.
There is a number of research programmes into the genetics, immunology and physiology of kidney disease and kidney transplantation. We maintain close links between basic scientists and clinicians with many translational programmes of work, from the laboratory to first-in-man and phase III clinical trials. Specific areas:
We have particular interests in:
Novel non-invasive methodologies using magnetic resonance are developed and applied to clinical research. Our research falls into two categories:
Our studies cover a broad range of topics (including diabetes, dementia, neuroscience, hepatology, cardiovascular, neuromuscular disease, metabolism, and respiratory research projects), but have a common theme of MR technical development and its application to clinical research.
We focus on connective tissue diseases in three, overlapping research programmes. These programmes aim to understand:
This research theme links with other local, national and international centres of excellence and has close integration of basic and clinical researchers and hosts the only immunotherapy centre in the UK.
Genetic approaches to the individualisation of drug therapy, including anticoagulants and anti-cancer drugs, and in the genetics of diverse non-Mendelian diseases, from diabetes to periodontal disease, are a focus. A wide range of knowledge and experience in both genetics and clinical sciences is utilised, with access to high-throughput genotyping platforms.
Our scientists and clinicians use in situ cellular technologies and large-scale gene expression profiling to study the normal and pathophysiological remodelling of vascular and uteroplacental tissues. Novel approaches to cellular interactions have been developed using a unique human tissue resource. Our research themes include:
We also have preclinical molecular biology projects in breast cancer research.
We conduct a broad range of research activities into acute and chronic lung diseases. As well as scientific studies into disease mechanisms, there is particular interest in translational medicine approaches to lung disease, studying human lung tissue and cells to explore potential for new treatments. Our current areas of research include:
Our research projects are concerned with the harmful effects of chemicals, including prescribed drugs, and finding ways to prevent and minimise these effects. We are attempting to measure the effects of fairly small amounts of chemicals, to provide ways of giving early warning of the start of harmful effects. We also study the adverse side-effects of medicines, including how conditions such as liver disease and heart disease can develop in people taking medicines for completely different medical conditions. Our current interests include: environmental chemicals and organophosphate pesticides, warfarin, psychiatric drugs and anti-cancer drugs.
Our new School of Pharmacy has scientists and clinicians working together on all aspects of pharmaceutical sciences and clinical pharmacy.